Balanced Salt

Product NDC

17478-921

11-digit product format

174780921

Labeler code

17478

Product ID

17478-921_c1ae6cb3-3537-4eb9-902e-6ccb3ab8f1dc

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Sodium Chloride, Potassium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Acetate and Trisodium Citrate Dihydrate

Dosage form

SOLUTION

Route

OPHTHALMIC

Labeler

Akorn

Application

ANDA075503

Marketing category

ANDA

Marketing start

2014-11-27

Marketing end

0000-00-00

Substance

CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; TRISODIUM CITRATE DIHYDRATE

Active strength

0 mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL

Pharmacologic classes

Acidifying Activity [MoA], Anti-coagulant [EPC], Blood Coagulation Factor [EPC], Calcium Chelating Activity [MoA], Calcium [CS], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Decreased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

NDC exclude flag

No

Listing certified through

2023-12-31

Current FDA listing

Historical FDA.report record